A Comprehensive Review of the Biochemical Analysis of Cyamopsis Tetragonoloba (L) for Anti-Parkinson's Activity

Abstract

Parkinson's disease (PD) is a neurological disorder that is commonly characterized by tremor, loss of motor abilities and progressive muscle rigidity. The disorder is linked to a progressive loss of brain nerve cells as well as a reduction in dopamine synthesis, which results in movement symptoms. While there is currently no known cure for Parkinson's disease (PD), some medicinal plants, such as Cyamopsis tetragonoloba, offer extracts and components that may help patients with the disease's symptoms and avoid impairment. The legume crop Cyamopsis tetragonoloba, (Guar) is grown in desert regions of Pakistan and India; India produces 90% of the world's Cyamopsis tetragonoloba (Guar) beans. Because of their high protein and amino acid contents, both plants are considered nutritious. The general Bio-chemical components of Cyamopsis tetragonoloba (Guar beans), such as fatty acids and amino acids, were examined. The amount of proteins, lipids, and total hydrolysable carbs in Guar beans was high. The percentage of linoleic acid in guar beans was considerable (25.41 and 48.99%, respectively). Guar beans contain significant amounts of glutamic, arginine, leucine, and aspartic acid for a wide range of uses, resulting in a rich supply of essential and non-essential amino acids. This review focuses on the therapeutic effects of a few anti-Parkinson's medications, and the information it contains may be implemented to identify new therapeutic compounds that may be used to treat parkins disease.